Gene · 57007
NIH grants2,255
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,255
Download this page as JSON| Grant | Title | ACKR3 papers | Newest fiscal year |
|---|---|---|---|
| F32AI181339 | Genetic and Molecular Mechanisms of hypermobile Ehlers Danlos Syndrome | 1 | 2025 |
| I01BX001957 | Reprogramming tumor associated macrophages to induce anti-tumor immune responses in bone metastatic breast cancer. | 1 | 2025 |
| I01BX002301 | Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival | 1 | 2025 |
| I01BX004115 | New Approaches to Combat CNS Inflammation: Targeting a Metabolic Enzyme in Demyelinating Disease | 1 | 2025 |
| K08AR078251 | Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathway | 1 | 2025 |
| K08CA270417 | Elucidating cancer-intrinsic mechanisms of perineural invasion in pancreatic cancer | 1 | 2025 |
| K08HL153945 | Protective role of CXCR7 in neonatal hyperoxia-induced systemic vascular dysfunction in adulthood | 1 | 2025 |
| K08NS116161 | Mural stem cells in normal development and germinal matrix hemorrhage in the preterm human brain | 1 | 2025 |
| K08NS133290 | Interrogating and Targeting Microglia Phagocytosis in Alzheimer’s Disease | 1 | 2025 |
| K12CA090433 | PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAM | 1 | 2025 |
| K12CA167540 | Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology | 1 | 2025 |
| K12EY016335 | Harvard-Vision Clinical Scientist Development Program | 1 | 2025 |
| K12GM068524 | San Diego IRACDA Scholars Program | 1 | 2025 |
| K12HD001399 | Child Health Research Career Development Award (CHRCDA) Program at Children's National | 1 | 2025 |
| K24HL137013 | Mentoring Research in Precision Medicine for Lung Disease | 1 | 2025 |
| P01AG036695 | Molecular Regulation of Stem Cell Aging | 1 | 2025 |
| P01AI108545 | Synergies among inhibitory receptors in tolerance and disease | 1 | 2025 |
| P01AI177687 | Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination | 1 | 2025 |
| P01CA049605 | Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma | 1 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/grants?page=5